AASLD, November 14, 2021：ECC0509, a novel peripherally distributed and selective semicarbazidesensitive amino oxidase (SSAO) inhibitor for NASH treatment

ILC, June 22, 2022：ECC4703, a full thyroid hormone receptor β (THRβ) agonist, demonstrates excellent selectivity and liver targeting properties and improvement of plasma lipids, NAFLD activity score and fibrosis in NASH animal model